Molecular mechanisms underlying chemopreventive potential of curcumin: Current challenges and future perspectives

Life Sciences

Volumn 148, Issue , 2016, Pages 313-328

  Kumar, Gaurav ^a   Mittal, Sonam ^b   Sak, Katrin ^c   Tuli, Hardeep Singh ^d  

^a UNIVERSITY OF DELHI   (India)

^b JAWAHARLAL NEHRU UNIVERSITY   (India)

^c UNIVERSITY OF TARTU   (Estonia)

^d MAHARISHI MARKANDESHWAR DEEMED TO BE UNIVERSITY   (India)

Author keywords

Angiogenesis; Anti cancer action; Apoptosis; Curcumin; Toxicity profile

Indexed keywords

AROMATIC HYDROCARBON RECEPTOR; CURCUMIN; HIGH MOBILITY GROUP B1 PROTEIN; IMMUNOGLOBULIN ENHANCER BINDING PROTEIN; MICRORNA; TRANSCRIPTION FACTOR NRF2; ANTINEOPLASTIC AGENT; ANTIOXIDANT;

ANTIANGIOGENIC ACTIVITY; APOPTOSIS; AUTOPHAGY; CANCER CHEMOTHERAPY; CELL CYCLE PROGRESSION; CELL CYCLE REGULATION; CELL DEATH; CHEMOPROPHYLAXIS; DIET SUPPLEMENTATION; DOWN REGULATION; DRUG BIOAVAILABILITY; DRUG DELIVERY SYSTEM; DRUG MECHANISM; DRUG POTENCY; HUMAN; IMMUNE RESPONSE; IN VIVO STUDY; MICROTUBULE ASSEMBLY; NONHUMAN; OUTCOME ASSESSMENT; REVIEW; STUDY; TUMOR GROWTH; ANIMAL; DRUG EFFECTS; FORECASTING; METABOLISM; MITOCHONDRIAL MEMBRANE; NEOPLASMS; PHYSIOLOGY;

ANIMALS; ANTINEOPLASTIC AGENTS; ANTIOXIDANTS; APOPTOSIS; CURCUMIN; FORECASTING; HUMANS; MITOCHONDRIAL MEMBRANES; NEOPLASMS;

EID: 84959335111     PISSN: 00243205     EISSN: 18790631     Source Type: Journal    
DOI: 10.1016/j.lfs.2016.02.022     Document Type: Review

References (279)

1. A. Nawaz, G.M. Khan, A. Hussain, A. Ahmad, A. Khan, and M. Safdar Curcumin: a natural product of biological importance Gomal Univ. J. Res. 27 2011 07 14
2. T.L. Zern, and M.L. Fernandez Cardioprotective effects of dietary polyphenols J. Nutr. Biochem. 135 2005 2291 2294
3. P. Anand, A.B. Kunnumakkara, R.A. Newman, and B. Aggarwal Bioavailability of curcumin: problems and promises Mol. Pharm. 4 2007 807 818
4. P. Anand, S.G. Thomas, A.B. Kunnumakkara, C. Sundaram, K.B. Harikumar, B. Sung, S.T. Tharakan, K. Misra, I.K. Priyadarsini, and K.N. Rajasekharan Biological activities of curcumin and its analogues (congeners) made by man and mother nature Biochem. Pharmacol. 76 2008 1590 1611
5. A. Asai, and T. Miyazawa Occurrence of orally administered curcuminoid as glucuronide and glucuronide/sulfate conjugates in rat plasma Life Sci. 67 2000 2785 2793
6. C. Ireson, S. Orr, D.J. Jones, R. Verschoyle, C.K. Lim, J.L. Luo, L. Howells, S. Plummer, R. Jukes, and M. Williams Characterization of metabolites of the chemopreventive agent curcumin in human and rat hepatocytes and in the rat in vivo, and evaluation of their ability to inhibit phorbol ester-induced prostaglandin E2 production Cancer Res. 61 2001 1058 1064
7. M.H. Pan, T.M. Huang, and J.K. Lin Biotransformation of curcumin through reduction and glucuronidation in mice Drug Metab. Dispos. 27 1999 486 494
8. S. Prasad, A.K. Tyagi, and B.B. Aggarwal Recent developments in delivery, bioavailability, absorption and metabolism of curcumin: the golden pigment from golden spice Cancer Res. Treat. 46 2014 2 18
9. R.A. Sharma, H.R. McLelland, K.A. Hill, C.R. Ireson, S.A. Euden, M.M. Manson, M. Pirmohamed, L.J. Marnett, A.J. Gescher, and W.P. Steward Pharmacodynamic and pharmacokinetic study of oral curcuma extract in patients with colorectal cancer Clin. Cancer Res. 7 2001 1894 1900
10. K. Namratha, P. Shenai, L. Chatra, V.K. Prasanna Kumar Rao, and R.V. Prabhu Antioxidant and anticancer effects of curcumin - a review J. Contemp. Med. 3 2013 136 143
11. T.W. Tan, H.R. Tsai, H.F. Lu, H.L. Lin, M.F. Tsou, Y.T. Lin, H.Y. Tsai, Y.F. Chen, and J.G. Chung Curcumin-induced cell cycle arrest and apoptosis in human acute promyelocytic leukemia HL-60 cells via MMP changes and caspase-3 activation Anticancer Res. 26 2006 4361 4371
12. H. Zhou, C.S. Beevers, and S. Huang The targets of curcumin. Curr. Drug Targets 12 2011 332 347
13. S.S. Lin, H.P. Huang, J.S. Yang, J.Y. Wu, T.C. Hsai, C.C. Lin, C.W. Lin, C.L. Kuo, W.G. Wood, and J.G. Chung DNA damage and endoplasmic reticulum stress mediated curcumin-induced cell cycle arrest and apoptosis in human lung carcinoma A-549 cells through the activation caspases cascade-and mitochondrial-dependent pathway Cancer Lett. 272 2008 77 90
14. S. Yodkeeree, W. Chaiwangyen, S. Garbisa, and P. Limtrakul Curcumin, demethoxycurcumin and bisdemethoxycurcumin differentially inhibit cancer cell invasion through the down-regulation of MMPs and uPA J. Nutr. Biochem. 20 2009 87 95
15. M. Banerjee, P. Singh, and D. Panda Curcumin suppresses the dynamic instability of microtubules, activates the mitotic checkpoint and induces apoptosis in mcf-7 cells FEBS J. 277 2010 3437 3448
16. H. Zhu, C. Bian, J. Yuan, W. Chu, X. Xiang, F. Chen, C. Wang, H. Feng, and J. Lin Curcumin attenuates acute inflammatory injury by inhibiting the TLR4/MyD88/NF-κB signaling pathway in experimental traumatic brain injury J. Neuroinflammation 11 2014 59
17. G. Kumar, H.S. Tuli, S. Mittal, J.K. Shandilya, A. Tiwari, and S.S. Sandhu Isothiocyanates: a class of bioactive metabolites with chemopreventive potential Tumor Biol. 36 2015 4005 4016
18. H.P. Ciolino, P.J. Daschner, T.T. Wang, and G.C. Yeh Effect of curcumin on the aryl hydrocarbon receptor and cytochrome P450 1A1 in MCF-7 human breast carcinoma cells Biochem. Pharmacol. 56 1998 197 206
19. P.Y. Cheng, M. Wang, and E.T. Morgan Rapid transcriptional suppression of rat cytochrome P450 genes by endotoxin treatment and its inhibition by curcumin J. Pharmacol. Exp. Ther. 307 2003 1205 1212
20. S.P. Valentine, M.J. Le Nedelec, A.R. Menzies, M.J. Scandlyn, M.G. Goodin, and R.J. Rosengren Curcumin modulates drug metabolizing enzymes in the female Swiss Webster mouse Life Sci. 78 2006 2391 2398
21. H. Choi, Y.S. Chun, Y.J. Shin, S.K. Ye, M.S. Kim, and J.W. Park Curcumin attenuates cytochrome P450 induction in response to 2,3,7,8-tetrachlorodibenzo-p-dioxin by ROS-dependently degrading AhR and ARNT Cancer Sci. 99 2008 2518 2524
22. R. Garg, S. Gupta, and G.B. Maru Dietary curcumin modulates transcriptional regulators of phase I and phase II enzymes in benzo[a]pyrene-treated mice: mechanism of its anti-initiating action Carcinogenesis 29 2008 1022 1032
23. A.L. Rinaldi, M.A. Morse, H.W. Fields, D.A. Rothas, P. Pei, K.A. Rodrigo, R.J. Renner, and S.R. Mallery Curcumin activates the aryl hydrocarbon receptor yet significantly inhibits (-)-benzo(a)pyrene-7R-trans-7,8-dihydrodiol bioactivation in oral squamous cell carcinoma cells and oral mucosa Cancer Res. 62 2002 5451 5456
24. A. Mohammadi-Bardbori, J. Bengtsson, U. Rannug, A. Rannug, and E. Wincent Quercetin, resveratrol, and curcumin are indirect activators of the aryl hydrocarbon receptor (AHR) Chem. Res. Toxicol. 25 2012 1878 1884
25. E.O. Farombi, S. Shrotriya, H.K. Na, S.H. Kim, and Y.J. Surh Curcumin attenuates dimethylnitrosamine-induced liver injury in rats through Nrf2-mediated induction of heme oxygenase-1 Food Chem. Toxicol. 46 2008 1279 1287
26. H.J. He, G.Y. Wang, Y. Gao, W.H. Ling, Z.W. Yu, and T.R. Jin Curcumin attenuates Nrf2 signaling defect, oxidative stress in muscle and glucose intolerance in high fat diet-fed mice World J. Diabetes 3 2012 94
27. Y. Öner-̄yidoʇan, S. TanrIkulu-Küçük, M. Seyithanoʇlu, H. Koçak, S. Doʇru-Abbasoʇlu, A.F. AydIn, Ş. Beyhan-Özdaş, H. YapIşlar, and N. Koçak-Toker Effect of curcumin on hepatic heme oxygenase 1 expression in high fat diet fed rats: is there a triangular relationship? Can. J. Physiol. Pharmacol. 92 2014 805 812
28. L. Liu, Y. Shang, M. Li, X. Han, J. Wang, and J. Wang Curcumin ameliorates asthmatic airway inflammation by activating nuclear factor-E2-related factor 2/haem oxygenase (HO)-1 signalling pathway Clin. Exp. Pharmacol. Physiol. 42 2015 520 529
29. S. González-Reyes, S. Guzmán-Beltrán, O.N. Medina-Campos, and J. Pedraza-Chaverri Curcumin pretreatment induces Nrf2 and an antioxidant response and prevents hemin-induced toxicity in primary cultures of cerebellar granule neurons of rats Oxidative Med. Cell. Longev. 2013 2013 1 14
30. T. Esatbeyoglu, K. Ulbrich, C. Rehberg, S. Rohn, and G. Rimbach Thermal stability, antioxidant, and anti-inflammatory activity of curcumin and its degradation product 4-vinyl guaiacol Food Funct. 6 2015 887 893
31. C.K. Andreadi, L.M. Howells, P.A. Atherfold, and M.M. Manson Involvement of Nrf2, p38, B-Raf, and nuclear factor-κB, but not phosphatidylinositol 3-kinase, in induction of hemeoxygenase-1 by dietary polyphenols Mol. Pharmacol. 69 2006 1033 1040
32. X. Kou, M. Kirberger, Y. Yang, and N. Chen Natural products for cancer prevention associated with Nrf2-ARE pathway Food Sci. Hum. Wellness 2 2013 22 28
33. N.S. Alrawaiq, and A. Abdullah Dietary phytochemicals activate the redox-sensitive transcription factor Nrf2 Int. J. Pharm. Sci. 6 2014 11 16
34. J. Wu, Q. Li, X. Wang, S. Yu, L. Li, X. Wu, Y. Chen, J. Zhao, and Y. Zhao Neuroprotection by curcumin in ischemic brain injury involves the Akt/Nrf2 pathway PLoS One 8 2013 e59843
35. G.N. Kim, Y.J. Lee, J.H. Song, and H.D. Jang Curcumin ameliorates AAPH-induced oxidative stress in HepG2 cells by activating Nrf2 Food Sci. Biotechnol. 22 2013 241 247
36. T.O. Khor, Y. Huang, T.Y. Wu, L. Shu, J. Lee, and A.N.T. Kong Pharmacodynamics of curcumin as DNA hypomethylation agent in restoring the expression of Nrf2 via promoter CpGs demethylation Biochem. Pharmacol. 82 2011 1073 1078
37. G.R. Pillai, A.S. Srivastava, T.I. Hassanein, D.P. Chauhan, and E. Carrier Induction of apoptosis in human lung cancer cells by curcumin Cancer Lett. 208 2004 163 170
38. S. Shishodia, H.M. Amin, R. Lai, and B.B. Aggarwal Curcumin (diferuloylmethane) inhibits constitutive NF-κB activation, induces G1/S arrest, suppresses proliferation, and induces apoptosis in mantle cell lymphoma Biochem. Pharmacol. 70 2005 700 713
39. S. Shankar, S. Ganapathy, Q. Chen, and R.K. Srivastava Curcumin sensitizes TRAIL-resistant xenografts: molecular mechanisms of apoptosis, metastasis and angiogenesis Mol. Cancer 7 2008 7 16
40. T. Choudhuri, S. Pal, T. Das, and G. Sa Curcumin selectively induces apoptosis in deregulated cyclin D1-expressed cells at G2 phase of cell cycle in a p53-dependent manner J. Biol. Chem. 280 2005 20059 20068
41. C. Beevers, F. Li, L. Liu, and S. Huang Curcumin inhibits the mammalian target of rapamycin-mediated signaling pathways in cancer cells Int. J. Cancer 119 2006 757 764
42. D.S. Lee, M.K. Lee, and J.H. Kim Curcumin induces cell cycle arrest and apoptosis in human osteosarcoma (HOS) cells Anticancer Res. 29 2009 5039 5044
43. H.Q. Li, L.J. Jin, F.F. Wu, X.Y. Li, J.S. You, Z.H. Cao, D. Li, and Y. Xu Effect of curcumin on proliferation, cell cycle, and caspases and MCF-7 cells Afr. J. Pharm. Pharmacol. 6 2012 864 870
44. A. Hussain, M. Al-Rasheed, P. Manogaran, K. Al-Hussein, L. Platanias, K. Al Kuraya, and S. Uddin Curcumin induces apoptosis via inhibition of PI3′-kinase/AKT pathway in acute T cell leukemias Apoptosis 11 2006 245 254
45. G.G. Mackenzie, N. Queisser, M.L. Wolfson, C.G. Fraga, A.M. Adamo, and P.I. Oteiza Curcumin induces cell-arrest and apoptosis in association with the inhibition of constitutively active NF-jB and STAT3 pathways in Hodgkin's lymphoma cells Int. J. Cancer 123 2008 56 65
46. N.M. Weir, K. Selvendiran, V.K. Kutala, L. Tong, S. Vishwanath, M. Rajaram, S. Tridandapani, S. Anant, and P. Kuppusamy Curcumin induces G2/M arrest and apoptosis in cisplatin-resistant human ovarian cancer cells by modulating Akt and p38 MAPK Cancer Biol. Ther. 6 2007 178 184
47. R.K. Srivastava, Q. Chen, I. Siddiqui, K. Sarva, and S. Shankar Linkage of curcumin-induced cell cycle arrest and apoptosis by cyclin-dependent kinase inhibitor p21/WAF1/CIP1 Cell Cycle 6 2007 2953 2961
48. S.H. Wu, L.W. Hang, J.S. Yang, H.Y. Chen, H.Y. Lin, J.H. Chiang, C.C. Lu, J.L. Yang, T.Y. Lai, and Y.C. Ko Curcumin induces apoptosis in human non-small cell lung cancer NCI-H460 cells through ER stress and caspase cascade-and mitochondria-dependent pathways Anticancer Res. 30 2010 2125 2133
49. R. Sahu, S. Batra, and S. Srivastava Activation of ATM/Chk1 by curcumin causes cell cycle arrest and apoptosis in human pancreatic cancer cells Br. J. Cancer 100 2009 1425 1433
50. C.L. Yang, Y.Y. Liu, Y.G. Ma, Y.X. Xue, D.G. Liu, Y. Ren, X.B. Liu, Y. Li, and Z. Li Curcumin blocks small cell lung cancer cells migration, invasion, angiogenesis, cell cycle and neoplasia through Janus kinase-STAT3 signalling pathway PLoS One 7 2012 e37960
51. N. Hasima, and B. Ozpolat Regulation of autophagy by polyphenolic compounds as a potential therapeutic strategy for cancer Cell Death Dis. 5 2014 e1509
52. Y.L. Jia, J. Li, Z.H. Qin, and Z.Q. Liang Autophagic and apoptotic mechanisms of curcumin-induced death in K562 cells J. Asian Nat. Prod. Res. 11 2009 918 928
53. J.Y. Kim, T.J. Cho, B.H. Woo, K.U. Choi, C.H. Lee, M.H. Ryu, and H.R. Park Curcumin-induced autophagy contributes to the decreased survival of oral cancer cells Arch. Oral Biol. 57 2012 1018 1025
54. Y. Yamauchi, Y. Izumi, K. Asakura, Y. Hayashi, and H. Nomori Curcumin induces autophagy in ACC-MESO-1 cells Phytother. Res. 26 2012 1779 1783
55. G. Mosieniak, M. Adamowicz, O. Alster, H. Jaskowiak, A.A. Szczepankiewicz, G.M. Wilczynski, I.A. Ciechomska, and E. Sikora Curcumin induces permanent growth arrest of human colon cancer cells: link between senescence and autophagy Mech. Ageing Dev. 133 2012 444 455
56. G.Z. Zhou, G.C. Sun, and S.N. Zhang The interplay between autophagy and apoptosis induced by one synthetic curcumin derivative hydrazinobenzoylcurcumin in A549 lung cancer cells J. Biochem. Mol. Toxicol. 29 2015 267 273
57. H. Aoki, Y. Takada, S. Kondo, R. Sawaya, B.B. Aggarwal, and Y. Kondo Evidence that curcumin suppresses the growth of malignant gliomas in vitro and in vivo through induction of autophagy: role of Akt and extracellular signal-regulated kinase signaling pathways Mol. Pharmacol. 72 2007 29 39
58. M. Katamura, E. Iwai-Kanai, M. Nakaoka, Y. Okawa, M. Ariyoshi, Y. Mita, A. Nakamura, K. Ikeda, T. Ogata, T. Ueyama, and S. Matoba Curcumin attenuates dxorubicin-induced cardiotoxicity by inducing autophagy via the regulation of JNK phosphorylation J. Clin. Exp. Cardiol. 5 2014 337
59. M.J. Park, E.H. Kim, I.C. Park, H.C. Lee, S.H. Woo, J.Y. Lee, Y.J. Hong, C.H. Rhee, S.H. Choi, and B.S. Shim Curcumin inhibits cell cycle progression of immortalized human umbilical vein endothelial (ECV304) cells by up-regulating cyclin-dependent kinase inhibitor, p21WAF1/CIP1, p27KIP1 and p53 Int. J. Oncol. 21 2002 379 383
60. M. Zheng, S. Ekmekcioglu, E.T. Walch, C.H. Tang, and E.A. Grimm Inhibition of nuclear factor-κB and nitric oxide by curcumin induces G2/M cell cycle arrest and apoptosis in human melanoma cells Melanoma Res. 14 2004 165 171
61. B.B. Aggarwal, S. Banerjee, U. Bharadwaj, B. Sung, S. Shishodia, and G. Sethi Curcumin induces the degradation of cyclin E expression through ubiquitin-dependent pathway and up-regulates cyclin-dependent kinase inhibitors p21 and p27 in multiple human tumor cell lines Biochem. Pharmacol. 73 2007 1024 1032
62. C. Park, G.Y. Kim, G.D. Kim, B.T. Choi, Y.M. Park, and Y.H. Choi Induction of G2/M arrest and inhibition of cyclooxygenase-2 activity by curcumin in human bladder cancer T24 cells Oncol. Rep. 15 2006 1225 1231
63. M.L.B. Carneiro, E.P. Porfírio, A.H. Otake, R. Chammas, S.N. Báo, and L.A. Guillo Morphological alterations and G0/G1 cell cycle arrest induced by curcumin in human SK-MEL-37 melanoma cells Braz. Arch. Biol. Technol. 53 2010 343 352
64. H.S. Liu, C.S. Ke, H.C. Cheng, C.Y.F. Huang, and C.L. Su Curcumin-induced mitotic spindle defect and cell cycle arrest in human bladder cancer cells occurs partly through inhibition of Aurora A Mol. Pharmacol. 80 2011 638 646
65. S. Yogosawa, Y. Yamada, S. Yasuda, Q. Sun, K. Takizawa, and T. Sakai Dehydrozingerone, a structural analogue of curcumin, induces cell-cycle arrest at the G2/M phase and accumulates intracellular ROS in HT-29 human colon cancer cells J. Nat. Prod. 75 2012 2088 2093
66. D. Kashyap, H.S. Tuli, and A.K. Sharma Ursolic acid (UA): a metabolite with promising therapeutic potential Life Sci. 2015 10.1016/j.lfs.2016.01.017
67. H.S. Tuli, D. Kashyap, S.K. Bedi, P. Kumar, G. Kumar, and S.S. Sandhu Molecular aspects of metal oxide nanoparticles (MO-Nps) mediated pharmacological effects Life Sci. 2015 10.1016/j.lfs.2015.10.021
68. C. Xu, G. Shen, C. Chen, C. Gélinas, and A.N.T. Kong Suppression of NF-κB and NF-κB-regulated gene expression by sulforaphane and PEITC through IκBα, IKK pathway in human prostate cancer PC-3 cells Oncogene 24 2005 4486 4495
69. C.H. Lee, Y.T. Jeon, S.H. Kim, and Y.S. Song NF-κB as a potential molecular target for cancer therapy Biofactors 29 2007 19 35
70. C.V. Rao Regulation of COX and LOX by curcumin, the molecular targets and therapeutic uses of curcumin in health and disease Adv. Exp. Med. Biol. 595 2007 213 226
71. B. Sun, and M. Karin NF-κB signaling, liver disease and hepatoprotective agents Oncogene 27 2008 6228 6244
72. S.S. Han, Y.S. Keum, H.J. Seo, and Y.J. Surh Curcumin suppresses activation of NF-κB and AP-1 induced by phorbol ester in cultured human promyelocytic leukemia cells BMB Rep. 35 2002 337 342
73. A.C. Bharti, N. Donato, S. Singh, and B.B. Aggarwal Curcumin (diferuloylmethane) down-regulates the constitutive activation of nuclear factor-κB and IκBα kinase in human multiple myeloma cells, leading to suppression of proliferation and induction of apoptosis Blood 101 2003 1053 1062
74. Y.T. Jian, G.F. Mai, J.D. Wang, Y.L. Zhang, R.C. Luo, and Y.X. Fang Preventive and therapeutic effects of NF-kappaB inhibitor curcumin in rats colitis induced by trinitrobenzene sulfonic acid World J. Gastroenterol. 11 2005 1747 1752
75. S. Aggarwal, H. Ichikawa, Y. Takada, S.K. Sandur, S. Shishodia, and B.B. Aggarwal Curcumin (diferuloylmethane) down-regulates expression of cell proliferation and antiapoptotic and metastatic gene products through suppression of IκBα kinase and Akt activation Mol. Pharmacol. 69 2006 195 206
76. S. Shishodia, P. Potdar, C.G. Gairola, and B.B. Aggarwal Curcumin (diferuloylmethane) down-regulates cigarette smoke-induced NF-κB activation through inhibition of IκBα kinase in human lung epithelial cells: correlation with suppression of COX-2, MMP-9 and cyclin D1 Carcinogenesis 24 2003 1269 1279
77. T.L. Chiu, and C.C. Su Curcumin inhibits proliferation and migration by increasing the Bax to Bcl-2 ratio and decreasing NF-κBp65 expression in breast cancer MDA-MB-231 cells Int. J. Mol. Med. 23 2009 469 475
78. Q. Liu, W.T. Loo, S. Sze, and Y. Tong Curcumin inhibits cell proliferation of MDA-MB-231 and BT-483 breast cancer cells mediated by down-regulation of NFκB, cyclinD and MMP-1 transcription Phytomedicine 16 2009 916 922
79. H. Zong, F. Wang, Q.X. Fan, and L.X. Wang Curcumin inhibits metastatic progression of breast cancer cell through suppression of urokinase-type plasminogen activator by NF-kappa B signaling pathways Mol. Biol. Rep. 39 2012 4803 4808
80. D. Wang, M.S. Veena, K. Stevenson, C. Tang, B. Ho, J.D. Suh, V.M. Duarte, K.F. Faull, K. Mehta, and E.S. Srivatsan Liposome-encapsulated curcumin suppresses growth of head and neck squamous cell carcinoma in vitro and in xenografts through the inhibition of nuclear factor κB by an AKT-independent pathway Clin. Cancer Res. 14 2008 6228 6236
81. W.G. Yu, G. Xu, G.J. Ren, X. Xu, H.Q. Yuan, X.L. Qi, and K.L. Tian Preventive action of curcumin in experimental acute pancreatitis in mouse Indian J. Med. Res. 134 2011 717
82. Y. Abe, S. Hashimoto, and T. Horie Curcumin inhibition of inflammatory cytokine production by human peripheral blood monocytes and alveolar macrophages Pharmacol. Res. 39 1999 41 47
83. M. Belakavadi, and B.P. Salimath Mechanism of inhibition of ascites tumor growth in mice by curcumin is mediated by NF-kB and caspase activated DNase Mol. Cell. Biochem. 273 2005 57 67
84. M.A. Khan, S. Gahlot, and S. Majumdar Oxidative stress induced by curcumin promotes the death of cutaneous T-cell lymphoma (HuT-78) by disrupting the function of several molecular targets Mol. Cancer Ther. 11 2012 1873 1883
85. A.M. Katsori, A. Palagani, N. Bougarne, D. Hadjipavlou-Litina, G. Haegeman, and Berghe W. Vanden Inhibition of the NF-κB signaling pathway by a novel heterocyclic curcumin analogue Molecules 20 2015 863 878
86. A. Olivera, T.W. Moore, F. Hu, A.P. Brown, A. Sun, D.C. Liotta, J.P. Snyder, Y. Yoon, H. Shim, and A.I. Marcus Inhibition of the NF-κB signaling pathway by the curcumin analog, 3, 5-Bis (2-pyridinylmethylidene)-4-piperidone (EF31): Anti-inflammatory and anti-cancer properties Int. Immunopharmacol. 12 2012 368 377
87. H.S. Tuli, A.K. Sharma, S.S. Sandhu, and D. Kashyap Cordycepin: a bioactive metabolite with therapeutic potential Life Sci. 93 23 2013 863 869
88. H.S. Tuli, A.K. Sharma, S.S. Sandhu, and D. Kashyap Molecular aspects of melatonin (MLT) mediated pharmacological effects Life Sci. 135 2015 147 157
89. H.S. Tuli, S. Sandhu, A.K. Sharma, and P. Gandhi Anti-angiogenic activity of the extracted fermentation broth of an entomopathogenic fungus, cordyceps militaris 3936 Int. J. Pharm. Pharm. Sci. 6 2014 581 583
90. A.K. Singh, G.S. Sidhu, T. Deepa, and R.K. Maheshwari Curcumin inhibits the proliferation and cell cycle progression of human umbilical vein endothelial cell Cancer Lett. 107 1996 109 115
91. J.L. Arbiser, N. Klauber, R. Rohan, R. van Leeuwen, M.T. Huang, C. Fisher, E. Flynn, and H.R. Byers Curcumin is an in vivo inhibitor of angiogenesis Mol. Med. 4 1998 376
92. R. Mohan, J. Sivak, P. Ashton, L.A. Russo, B.Q. Pham, N. Kasahara, M.B. Raizman, and M.E. Fini Curcuminoids inhibit the angiogenic response stimulated by fibroblast growth factor-2, including expression of matrix metalloproteinase gelatinase B J. Biol. Chem. 275 2000 10405 10412
93. M.K. Bae, S.H. Kim, J.W. Jeong, Y.M. Lee, H.S. Kim, S.R. Kim, I. Yun, S.K. Bae, and K.W. Kim Curcumin inhibits hypoxia-induced angiogenesis via down-regulation of HIF-1 Oncol. Rep. 15 2006 1557 1562
94. C. Premanand, M. Rema, M.Z. Sameer, M. Sujatha, and M. Balasubramanyam Effect of curcumin on proliferation of human retinal endothelial cells under in vitro conditions Invest. Ophthalmol. Vis. 47 2006 2179 2184
95. G.P. Nagaraju, S. Zhu, J.E. Ko, N. Ashritha, R. Kandimalla, J.P. Snyder, M. Shoji, and B.F. El-Rayes Antiangiogenic effects of a novel synthetic curcumin analogue in pancreatic cancer Cancer Lett. 357 2015 557 565
96. A.E. Gururaj, M. Belakavadi, D.A. Venkatesh, D. Marmé, and B.P. Salimath Molecular mechanisms of anti-angiogenic effect of curcumin Biochem. Biophys. Res. Commun. 297 2002 934 942
97. S. Ray, N. Chattopadhyay, A. Mitra, M. Siddiqi, and A. Chatterjee Curcumin exhibits antimetastatic properties by modulating integrin receptors, collagenase activity, and expression of Nm23 and E-cadherin J. Environ. Pathol. Toxicol. Oncol. 22 2003 49 58
98. S. Shishodia, M.M. Chaturvedi, and B.B. Aggarwal Role of curcumin in cancer therapy Curr. Probl. Cancer 31 2007 243 305
99. J. Hong, K. Ahn, E. Bae, S. Jeon, and H. Choi The effects of curcumin on the invasiveness of prostate cancer in vitro and in vivo Prostate Cancer Prostatic Dis. 9 2006 147 152
100. J.S. Shim, D.H. Kim, H.J. Jung, J.H. Kim, D. Lim, S.K. Lee, K.W. Kim, J.W. Ahn, J.S. Yoo, J.R. Rho, J. Shin, and H.J. Kwon Hydrazinocurcumin, a novel synthetic curcumin derivative, is a potent inhibitor of endothelial cell proliferation Bioorg. Med. Chem. 10 2002 2439 2444
101. E.R. Hahm, Y.S. Gho, S. Park, C. Park, K.W. Kim, and C.H. Yang Synthetic curcumin analogs inhibit activator protein-1 transcription and tumor-induced angiogenesis Biochem. Biophys. Res. Commun. 321 2004 337 344
102. K.W. Lee, J.H. Kim, H.J. Lee, and Y.J. Surh Curcumin inhibits phorbol ester-induced up-regulation of cyclooxygenase-2 and matrix metalloproteinase-9 by blocking ERK1/2 phosphorylation and NF-κB transcriptional activity in MCF10A human breast epithelial cells Antioxid. Redox Signal. 7 2005 1612 1620
103. M. Shakibaei, T. John, G. Schulze-Tanzil G, I. Lehmann, and A. Mobasheri Suppression of NF-κB activation by curcumin leads to inhibition of expression of cyclo-oxygenase-2 and matrix metalloproteinase-9 in human articular chondrocytes: Implications for the treatment of osteoarthritis Biochem. Pharmacol. 73 2007 1434 1445
104. J. Cao, Z. Han, L. Tian, K. Chen, Y. Fan, B. Ye, W. Huang, C. Wang, and Z. Huang Curcumin inhibits EMMPRIN and MMP-9 expression through AMPK-MAPK and PKC signaling in PMA induced macrophages J. Transl. Med. 12 2014 266
105. L.X. Chen, Y.J. He, S.Z. Zhao, J.G. Wu, J.T. Wang, L.M. Zhu, T.T. Lin, B.C. Sun, and X.R. Li Inhibition of tumor growth and vasculogenic mimicry by curcumin through down-regulation of the EphA2/PI3K/MMP pathway in a murine choroidal melanoma model Cancer Biol. Ther. 11 2011 229 235
106. E. Nogales Structural insight into microtubule function Annu. Rev. Biophys. Biomol. Struct. 30 2001 397 420
107. M.A. Jordan, and L. Wilson Microtubules as a target for anticancer drugs Nat. Rev. Cancer 4 2004 253 265
108. E. White Life death and the pursuit of apoptosis Genes Dev. 10 1996 1 15
109. C. Lengauer, K.W. Kinzler, and B. Vogelstein Genetic instabilities in human cancers Nature 396 1998 643 649
110. S.J. Jackson, and K.W. Singletary Sulforaphane inhibits human MCF-7 mammary cancer cell mitotic progression and tubulin polymerization J. Nutr. 134 2004 2229 2236
111. K.K. Gupta, S.S. Bharne, K. Rathinasamy, N.R. Naik, and D. Panda Dietary antioxidant curcumin inhibits microtubule assembly through tubulin binding FEBS J. 273 2006 5320 5332
112. S. Chakraborti, L. Das, N. Kapoor, A. Das, V. Dwivedi, A. Poddar, G. Chakraborti, M. Janik, G. Basu, and D. Panda Curcumin recognizes a unique binding site of tubulin J. Med. Chem. 54 2011 6183 6196
113. A. Arezki, G.G. Chabot, L. Quentin, D. Scherman, G. Jaouen, and E. Brulé Synthesis and biological evaluation of novel ferrocenyl curcuminoid derivatives Med. Chem. Commun. 2 2011 190 195
114. B.F. Ruan, X. Lu, T.T. Li, J.F. Tang, Y. Wei, X.L. Wang, S.L. Zheng, R.S. Yao, and H.L. Zhu Synthesis, biological evaluation and molecular docking studies of resveratrol derivatives possessing curcumin moiety as potent antitubulin agents Bioorg. Med. Chem. 20 2012 1113 1121
115. S.J. Jackson, L.L. Murphy, R.C. Venema, K.W. Singletary, and A.J. Young Curcumin binds tubulin, induces mitotic catastrophe, and impedes normal endothelial cell proliferation Food Chem. Toxicol. 60 2013 431 438
116. D. Choudhury, A. Ganguli, D.G. Dastidar, B.R. Acharya, A. Das, and G. Chakrabarti Apigenin shows synergistic anticancer activity with curcumin by binding at different sites of tubulin Biochimie 95 2013 1297 1309
117. S.L. Thomas, D. Zhong, W. Zhou, S. Malik, D. Liotta, J.P. Snyder, E. Hamel, and P. Giannakakou EF24, a novel curcumin analog, disrupts the microtubule cytoskeleton and inhibits HIF-1 Cell Cycle 7 2008 2409 2417
118. S. Sharma, T.K. Kelly, and P.A. Jones Epigenetics in cancer Carcinogenesis 31 2010 27 36
119. B.J. Morris Seven sirtuins for seven deadly diseases of aging Free Radic. Biol. Med. 56 2013 133 171
120. B.M. Zwaans, and D.B. Lombard Interplay between sirtuins, MYC and hypoxiainducible factor in cancer-associated metabolic reprogramming Dis. Model. Mech. 7 2014 1023 1032
121. I. Rahman Dietary polyphenols mediated regulation of oxidative stress and chromatin remodeling in inflammation Nutr. Rev. 66 2008 42 45
122. S. Chung, H. Yao, S. Caito, J.W. Hwang, G. Arunachalam, and I. Rahman Regulation of SIRT1 in cellular functions: role of polyphenols Arch. Biochem. Biophys. 501 2010 79 90
123. Q. Sun, N. Jia, W. Wang, H. Jin, J. Xu, and H. Hu Activation of SIRT1 by curcumin blocks the neurotoxicity of amyloid-β25-35in rat cortical neurons Biochem. Biophys. Res. Commun. 448 2014 89 94
124. A. Hu, J.J. Huang, R.L. Li, Z.Y. Lu, J.L. Duan, W.H. Xu, X.P. Chen, and J.P. Fan Curcumin as therapeutics for the treatment of head and neck squamous cell carcinoma by activating SIRT1 Sci. Rep. 5 2015 13429 10.1038/srep13429
125. L.R. Shen, L.D. Parnell, J.M. Ordovas, and C.Q. Lai Curcumin and aging Biofactors 39 2013 133 140
126. E. Sikora, A. Bielak-Zmijewska, G. Mosieniak, and K. Piwocka The promise of slowdown ageing may come from curcumin Curr. Pharm. Des. 16 2010 884 892
127. V.H. Liao, C.W. Yu, Y.J. Chu, W.H. Li, Y.C. Hsieh, and T.T. Wang Curcumin-mediated lifespan extension in Caenorhabditis elegans Mech. Ageing Dev. 132 2011 480 487
128. Y. Yang, W. Duan, Y. Lin, W. Yi, Z. Liang, J. Yan, N. Wang, C. Deng, S. Zhang, Y. Li, W. Chen, S. Yu, D. Yi, and Z. Jin SIRT1 activation by curcumin pretreatment attenuates mitochondrial oxidative damage induced by myocardial ischemia reperfusion injury Free Radic. Biol. Med. 65 2013 667 679
129. R.D. Ray Hamidie, T. Yamada, R. Ishizawa, Y. Saito, and K. Masuda Curcumin treatment enhances the effect of exercise on mitochondrial biogenesis in skeletal muscle by increasing cAMP levels Metab. Clin. Exp. 64 2004 1334 1347
130. C. Gerhäuser Cancer cell metabolism, epigenetics and the potential influence of dietary components - A perspective Biomed. Res. 23 2012 1 21
131. J. Trujillo, L.F. Granados-Castro, C. Zazueta, A.C. Andérica-Romero, Y.I. Chirino, and J. Pedraza-Chaverrí Mitochondria as a target in the therapeutic properties of curcumin Arch. Pharm. Chem. Life Sci. 347 2014 873 884
132. S. Doggui, A. Belkacemi, G.D. Paka, M. Perrotte, R. Pi, and C. Ramassamy Curcumin protects neuronal-like cells against acrolein by restoring akt and redox signaling pathways Mol. Nutr. Food Res. 57 2013 1660 1670
133. L.M. Jiménez-Flores, S. López-Briones, M.H. Macías-Cervantes, J. Ramírez-Emiliano, and V. Pérez-Vázquez A PPARγ, NF-κB and AMPK-dependent mechanism may be involved in the beneficial effects of curcumin in the diabetic db/db mice liver Molecules 19 2014 8289 8302
134. D.P. Bartel MicroRNAs: genomics, biogenesis, mechanism, and function Cell 116 2004 281 297
135. L. He, and G.J. Hannon MicroRNAs: small RNAs with a big role in gene regulation Nat. Rev. Genet. 5 2004 522 531
136. S. Volinia, G.A. Calin, C.G. Liu, S. Ambs, A. Cimmino, F. Petrocca, R. Visone, M. Iorio, C. Roldo, M. Ferracin, R.L. Prueitt, N. Yanaihara, G. Lanza, A. Scarpa, A. Vecchione, M. Negrini, C.C. Harris, and C.M. Croce A microRNA expression signature of human solid tumors defines cancer gene targets Proc. Natl. Acad. Sci. U. S. A. 103 2006 2257 2261
137. A. Ventura, and T. Jacks MicroRNAs and cancer: short RNAs go a long way Cell 136 2009 586 591
138. S.A. Melo, and M. Esteller Dysregulation of microRNAs in cancer: playing with fire FEBS Lett. 585 2010 2087 2099
139. L. Guo, Y. Zhang, L. Zhang, F. Huang, J. Li, and S. Wang MicroRNAs, TGF-βsignaling, and the inflammatory microenvironment in cancer Tumor Biol. 1-11 2015
140. G. Mudduluru, J.N. George-William, S. Muppala, I.A. Asangani, R. Kumarswamy, L.D. Nelson, and H. Allgayer Curcumin regulates miR-21 expression and inhibits invasion and metastasis in colorectal cancer Biosci. Rep. 31 2011 185 197
141. S.U. Gandhy, K. Kim, L. Larsen, R.J. Rosengren, and S. Safe Curcumin and synthetic analogs induce reactive oxygen species and decreases specificity protein (Sp) transcription factors by targeting microRNAs BMC Cancer 12 2012 1 12
142. S. Saini, S. Arora, S. Majid, V. Shahryari, Y. Chen, G. Deng, S. Yamamura, K. Ueno, and R. Dahiya Curcumin modulates microRNA-203-mediated regulation of the Src-Akt axis in bladder cancer cancer Prev. Res. 4 2011 1698 1709
143. S.M. Gao, J.J. Yang, C.Q. Chen, J.J. Chen, L.P. Ye, L.Y. Wang, J.B. Wu, C.Y. Xing, and K. Yu Pure curcumin decreases the expression of WT1 by upregulation of miR-15a and miR-16-1 in leukemic cells J. Exp. Clin. Cancer Res. 31 2012 27
144. S. Sreenivasan, K. Thirumalai, R. Danda, and S. Krishnakumar Effect of curcumin on miRNA expression in human Y79 retinoblastoma cells Curr. Eye Res. 37 2012 421 428
145. D. Subramaniam, S. Ponnurangam, P. Ramamoorthy, D. Standing, R.J. Battafarano, S. Anant, and P. Sharma Curcumin induces cell death in esophageal cancer cells through modulating notch signaling PLoS One 7 2012 30590
146. C.C. Yu, L.L. Tsai, M.L. Wang, C.H. Yu, W.L. Lo, Y.C. Chang, G.Y. Chiou, M.Y. Chou, and S.H. Chiou miR145 targets the SOX9/ADAM17 axis to inhibit tumor initiating cells and IL-6-mediated paracrine effects in head and neck cancer cancer Res. 73 2013 3425 3440
147. S. Ali, A. Ahmad, S. Banerjee, S. Padhye, K. Dominiak, J.M. Schaffert, Z. Wang, P.A. Philip, and F.H. Sarkar Gemcitabine sensitivity can be induced in pancreatic cancer cells through modulation of miR-200 and miR-21 expression by curcumin or its analogue CDF Cancer Res. 70 2010 3606 3617
148. B. Bao, S. Ali, S. Banerjee, Z. Wang, F. Logna, A.S. Azmi, D. Kong, A. Ahmad, Y. Li, S. Padhye, and F.H. Sarkar Curcumin analogue CDF inhibits pancreatic tumor growth by switching on suppressor microRNAs and attenuating EZH2 expression Cancer Res. 72 2011 335 345
149. C.H. Yang, J. Yue, M. Sims, and L.M. Pfeffer The curcumin analog EF24 targets NF-kB and miRNA-21, and has potent anticancer activity in vitro and in vivo PLoS One 8 2013 71130
150. D. Tang, R. Kang, H.J. Zeh 3rd, and M.T. Lotze High-mobility group Box1, oxidative stress, and disease Antioxid. Redox Signal. 14 2011 1315 1335
151. C. Wang, H. Nie, K. Li, Y.X. Zhang, F. Yang, C.B. Li, C.F. Wang, and Q. Gong Curcumin inhibits HMGB1 releasing and attenuates concanavalin A-induced hepatitis in mice Eur. J. Pharmacol. 697 2012 152 157
152. C.T. Tu, Q.Y. Yao, B.L. Xu, J.Y. Wang, C.H. Zhou, and S.C. Zhang Protective effects of curcumin against hepatic fibrosis induced by carbon tetrachloride: modulation of high-mobility group box 1, Toll-like receptor 4 and 2 expression Food Chem. Toxicol. 50 2012 3343 3351
153. Q. Gu, H. Guan, Q. Shi, Y. Zhang, and H. Yang Curcumin attenuated acute propionibacterium acnes-induced liver injury through inhibition of HMGB1 expression in mice Int. Immunopharmacol. 24 2015 159 165
154. T.Y. Ma, G.K. Iwamoto, N.T. Hoa, V. Akotia, A. Pedram, M.A. Boivin, and H.M. Said TNF-induced increase in intestinal epithelial tight junction permeability requires NF-κB activation Am. J. Physiol. Gastrointest. Liver Physiol. 286 2004 367 376
155. J.R. Rapin, and N. Wiernsperger Possible links between intestinal permeability and food processing: a potential therapeutic niche for glutamine Clinics (Sao Paulo) 65 2010 635 643
156. R.M. Al-Sadi, and T.Y. Ma IL-1 causes an increase in intestinal epithelial tight junction permeability J. Immunol. 178 2007 4641 4649
157. T. Ak, and I. Gulcin Antioxidant and radical scavenging properties of curcumin Chem. Biol. Interact. 174 2008 27 37
158. B.B. Aggarwal, and B. Sung Pharmacological basis for the role of curcumin in chronic diseases: an age-old spice with modern targets Trends Pharmacol. Sci. 30 2009 85 94
159. D. Ye, I. Ma, and T.Y. Ma Molecular mechanism of tumor necrosis factor-modulation of intestinal epithelial tight junction barrier Am. J. Physiol. Gastrointest. Liver Physiol. 290 2006 496 504
160. G.C. Jagetia, and B.B. Aggarwal Spicing up of the immune system by curcumin J. Clin. Immunol. 27 2007 19 35
161. E. Sikora, A. Bielak-Zmijewska, K. Piwocka, J. Skierski, and E. Radziszewska Inhibition of proliferation and apoptosis of human and rat T lymphocytes by curcumin, a curry pigment Biochem. Pharmacol. 54 1997 899 907
162. A. Magalska, A. Brzezinska, A. Bielak-Zmijewska, K. Piwocka, G. Mosieniak, and E. Sikora Curcumin induces cell death without oligonucleosomal DNA fragmentation in quiescent and proliferating human CD8 + cells Acta Biochim. Pol. 53 2006 531 538
163. G.Y. Kim, K.H. Kim, S.H. Lee, M.S. Yoon, H.J. Lee, D.O. Moon, and et al. Curcumin inhibits immunostimulatory function of dendritic cells: MAPKs and translocation of NFkappa B as potential targets J. Immunol. 174 2005 8116 8124
164. A. Kumar, S. Dhawan, N.J. Hardegen, and B.B. Aggarwal Curcumin (diferuloylmethane) inhibition of tumor necrosis factor (TNF)-mediated adhesion of monocytes to endothelial cells by suppression of cell surface expression of adhesion molecules and of nuclear factor-kappaB activation Biochem. Pharmacol. 55 1998 775 783
165. M. Fiala Curcumin and omega-3 fatty acids enhance NK cell-induced apoptosis of pancreatic cancer cells but curcumin inhibits interferon-γ production: benefits of omega-3 with curcumin against cancer Molecules 20 2015 3020 3026
166. R.C. Halder, A. Almasi, B. Sagong, J. Leung, A. Jewett, and M. Fiala Curcuminoids and ω-3 fatty acids with anti-oxidants potentiate cytotoxicity of natural killer cells against pancreatic ductal adenocarcinoma cells and inhibit interferon γ production Front. Physiol. 6 2015 129
167. S. Bhattacharyya, D. Md Sakib Hossain, S. Mohanty, G. Sankar Sen, S. Chattopadhyay, S. Banerjee, J. Chakraborty, K. Das, D. Sarkar, T. Das, and G. Sa Curcumin reverses T cell-mediated adaptive immune dysfunctions in tumor-bearing hosts Cell. Mol. Immunol. 7 2010 306 315
168. R.M. Srivastava, S. Singh, S.K. Dubey, K. Misra, and A. Khar Immunomodulatory and therapeutic activity of curcumin Int. Immunopharmacol. 11 2011 331 341
169. E.K. Rowinsky, H.M. Pinedo, and J.H. Schornagel Incorporating assessments of sequence-dependence in developmental studies of combination chemotherapy regimens containing new agents and platinum compounds Platinum and Other Metal Coordination Compounds in Cancer Chemotherapy 2 1996 Plenum Press New York
170. T.C. Chou Theoretical basis, experimental design, and computerized simulation of synergism and antagonism in drug combination studies Pharmacol. Rev. 58 2006 621 681
171. B. Du, L. Jiang, Q. Xia, and L. Zhong Synergistic inhibitory effects of curcumin and 5-fluorouracil on the growth of the human colon cancer cell line HT-29 Chemotherapy 52 2006 23 28
172. T. Andjelkovic, M. Pesic, J. Bankovic, N. Tanic, I.D. Markovic, and S. Ruzdijic Synergistic effects of the purine analog sulfinosine and curcumin on the multidrug resistant human non-small cell lung carcinoma cell line (NCI-H460/R) Cancer Biol. Ther. 7 2008 1024 1032
173. M.S. Tsai, S.H. Weng, Y.H. Kuo, Y.F. Chiu, and Y.W. Lin Synergistic effect of curcumin and cisplatin via down regulation of thymidine phosphorylase and excision repair cross-complementary 1 (ERCC1) Mol. Pharmacol. 80 2011 136 146
174. R. Ataee, A.S. Ahmadi, M. Shadifar, A. Ataie, C. Vaillancourt, M. Jafari-Sabet, and T. Oufkir Apoptosis is induced by curcumin in synergism with 5FU in human colorectal cancer cell line Sci.-Afric. J. Sci. Issues Res. Essays 2 2014 147 150
175. B.S. Vinod, J. Antony, H.H. Nair, V.T. Puliyappadamba, M. Saikia, S.S. Narayanan, A. Bevin, and R.J. Anto Mechanistic evaluation of the signaling events regulating curcumin-mediated chemosensitization of breast cancer cells to 5-fluorouracil Cell Death Dis. 4 2013 e505
176. B. Sivanantham, S. Sethuraman, and U.M. Krishnan Combinatorial effects of curcumin with an anti-neoplastic agent on head and neck squamous cell carcinoma through the regulation of EGFR-ERK1/2 and apoptotic signaling pathways ACS Comb. Sci. 18 2016 22 35
177. A. Cort, M. Timur, E. Ozdemir, E. Kucuksayan, and T. Ozben Synergistic anticancer activity of curcumin and bleomycin: an in vitro study using human malignant testicular germ cells Mol. Med. Rep. 5 2012 1481 1486
178. S. Lev-Ari, L. Strier, D. Kazanov, O. Elkayam, D. Lichtenberg, D. Caspi, and N. Arber Curcumin synergistically potentiates the growth-inhibitory and pro-apoptotic effects of celecoxib in osteoarthritis synovial adherent cells Rheumatology 45 2006 171 177
179. K. Shah, S. Mirza, U. Desai, N. Jain, and R. Rawal Synergism of curcumin and cytarabine in the down regulation of multi-drug resistance genes in acute myeloid leukemia Anti Cancer Agents Med. Chem. 16 2015 128 135
180. D.W. Eom, J.H. Lee, Y.J. Kim, G.S. Hwang, S.N. Kim, J.H. Kwak, G.J. Cheon, K.H. Kim, H.J. Jang, J. Ham, K.S. Kang, and N. Yamabe Synergistic effect of curcumin on epigallocatechin gallate-induced anticancer action in PC3 prostate cancer cells BMB Rep. 48 2015 461 466
181. C. Ramachandran, A.P. Resek, E. Escalon, A. Aviram, and S.J. Melnick Potentiation of gemcitabine by turmeric force in pancreatic cancer cell lines Oncol. Rep. 23 2010 1529 1535
182. M. Hossain, N.L. Banik, and S.K. Ray Synergistic anti-cancer mechanisms of curcumin and paclitaxel for growth inhibition of human brain tumor stem cells and LN18 and U138MG cells Neurochem. Int. 61 2011 1102 1113
183. Q. Du, B. Hu, H.M. An, K.P. Shen, L. Xu, S. Deng, and M.M. Wei Synergistic anticancer effects of curcumin and resveratrol in Hepa1-6 hepatocellular carcinoma cells Oncol. Rep. 29 2013 1851 1858
184. A. Mathur, Z.Y. Abd Elmageed, X. Liu, M.L. Kostochka, H. Zhang, A.B. Abdel-Mageed, and D. Mondal Subverting ER-stress towards apoptosis by nelfinavir and curcumin coexposure augments docetaxel efficacy in castration resistant prostate cancer cells PLoS One 9 2014 e103109
185. M. Jiang, O. Huang, X. Zhang, Z. Xie, A. Shen, H. Liu, M. Geng, and K. Shen Curcumin induces cell death and restores tamoxifen sensitivity in the antiestrogen-resistant breast cancer cell lines MCF-7/LCC2 and MCF-7/LCC9 Molecules 18 2013 701 720
186. S. Sreenivasan, and S. Krishnakumar Synergistic effect of curcumin in combination with anticancer agents in human retinoblastoma cancer cells lines Curr. Eye Res. 40 2015 1153 1165
187. J.D. Altenburg, A.A. Bieberich, C. Terry, K.A. Harvey, J.F. Vanhorn, Z. Xu, V. Jo Davisson, and R.A. Siddiqui A synergistic antiproliferation effect of curcumin and docosahexaenoic acid in SK-BR-3 breast cancer cells: unique signaling not explained by the effects of either compound alone BMC Cancer 11 2011 149
188. Y.Y. Cai, W.P. Lin, A.P. Li, and J.Y. Xu Combined effects of curcumin and triptolide on an ovarian cancer cell line Asian Pac. J. Cancer Prev. 14 2013 4267 4271
189. D. Shi, Y. Xu, X. Du, X. Chen, X. Zhang, J. Lou, M. Li, and J. Zhuo Co-treatment of THP-1 cells with naringenin and curcumin induces cell cycle arrest and apoptosis via numerous pathways Mol. Med. Rep. 12 2015 8223 8228
190. J.Y. Zhang, M.T. Lin, M.J. Zhou, T. Yi, Y.N. Tang, S.L. Tang, Z.J. Yang, Z.Z. Zhao, and H.B. Chen Combinational treatment of curcumin and quercetin against gastric cancer MGC-803 cells in vitro Molecules 20 2015 11524 11534
191. H. Huang, X. Chen, D. Li, Y. He, Y. Li, Z. Du, K. Zhang, R. DiPaola, S. Goodin, and X. Zheng Combination of α-tomatine and curcumin inhibits growth and induces apoptosis in human prostate cancer cells PLoS One 10 2015 e144293
192. N.P. Adityaa, M. Shimb, H. Yanga, Y. Lee, and S. Ko Antiangiogenic effect of combined treatment with curcumin and genistein on human prostate cancer cell line J. Funct. Foods 8 2014 204 213
193. P. Sindhwani, J.A. Hampton, M.M. Baig, R. Keck, and S.H. Selman Curcumin prevents intravesical tumor implantation of the MBT-2 tumor cell line in C3H mice J. Urol. 166 2001 1498 1501
194. Y. Okazaki, M. Iqbal, and S. Okada Suppressive effects of dietary curcumin on the increased activity of renal ornithine decarboxylase in mice treated with a renal carcinogen, ferric nitrilotriacetate Biochim. Biophys. Acta 2005 1740 357 366
195. M. Iqbal, Y. Okazaki, and S. Okada Curcumin attenuates oxidative damage in animals treated with a renal carcinogen, ferric nitrilotriacetate (Fe-NTA): implications for cancer prevention Mol. Cell. Biochem. 324 2009 157 164
196. C.V. Rao, B. Simi, and B.S. Reddy Inhibition by dietary curcumin of azoxymethane-induced ornithine decarboxylase, tyrosine protein kinase, arachidonic acid metabolism and aberrant crypt foci formation in the rat colon Carcinogenesis 14 1993 2219 2225
197. M.T. Huang, Y.R. Lou, W. Ma, H.L. Newmark, K.R. Reuhl, and A.H. Conney Inhibitory effects of dietary curcumin on forestomach, duodenal, and colon carcinogenesis in mice Cancer Res. 54 1994 5841 5847
198. J.M. Kim, S. Araki, D.J. Kim, C.B. Park, N. Takasuka, H. Baba-Toriyama, T. Ota, Z. Nir, F. Khachik, and N. Shimidzu Chemopreventive effects of carotenoids and curcumin on mouse colon carcinogenesis after 1, 2-dimethylhydrazine initiation Carcinogenesis 19 1998 81 85
199. G.P. Collett, C.N. Robson, J.C. Mathers, and F.C. Campbell Curcumin modifies apcmin apoptosis resistance and inhibits 2-amino 1-methyl-6-phenylimidazo [4, 5-b] pyridine (PhIP) induced tumour formation in apc(min) mice Carcinogenesis 22 2001 821 825
200. T. Tanaka, H. Makita, M. Ohnishi, Y. Hirose, A. Wang, H. Mori, K. Satoh, A. Hara, and H. Ogawa Chemoprevention of 4-nitroquinoline 1-oxide-induced oral carcinogenesis by dietary curcumin and hesperidin: comparison with the protective effect of beta-carotene Cancer Res. 54 1994 4653 4659
201. S. Manoharan, S. Balakrishnan, V. Menon, L. Alias, and A. Reena Chemopreventive efficacy of curcumin and piperine during 7, 12-dimethylbenz (a) anthracene-induced hamster buccal pouch carcinogenesis Singap. Med. J. 50 2009 139
202. M.A. Azuine, and S.V. Bhide Chemopreventive effect of turmeric against stomach and skin tumors induced by chemical carcinogens in Swiss mice Nutr. cancer 17 1992 77 83
203. S.V. Singh, X. Hu, S.K. Srivastava, M. Singh, H. Xia, J.L. Orchard, and H.A. Zaren Mechanism of inhibition of benzo [a] pyrene-induced forestomach cancer in mice by dietary curcumin Carcinogenesis 19 1998 1357 1360
204. S. Ikezaki, A. Nishikawa, F. Furukawa, K. Kudo, H. Nakamura, K. Tamura, and H. Mori Chemopreventive effects of curcumin on glandular stomach carcinogenesis induced by N-methyl-N′-nitro-N-nitrosoguanidine and sodium chloride in rats Anticancer Res. 21 2000 3407 3411
205. M.T. Huang, Z.Y.R. Lo, J.G. Xie, W. Ma, Y.P. Lu, P. Yen, B.T. Zhu, H. Newmark, and C.T. Ho Effect of dietary curcumin and dibenzoylmethane on formation of 7, 12-dimethylbenz [a] anthracene-induced mammary tumors and lymphomas/leukemias in sencar mice Carcinogenesis 19 1998 1697 1700
206. M.T. Huang, E. Deschner, H. Newmark, Z.Y. Wang, T. Ferraro, and A. Conney Effect of dietary curcumin and ascorbyl palmitate on azoxymethanol-induced colonic epithelial cell proliferation and focal areas of dysplasia Cancer Lett. 64 1992 117 121
207. Y.P. Lu, R.L. Chang, M.T. Huang, and A.H. Conney Inhibitory effect of curcumin on 12-O-tetradecanoylphorbol-13-acetate-induced increase in ornithine decarboxylase mRNA in mouse epidermis Carcinogenesis 14 1993 293 297
208. M.T. Huang, W. Ma, P. Yen, J.G. Xie, J. Han, K. Frenkel, D. Grunberger, and A.H. Conney Inhibitory effects of topical application of low doses of curcumin on 12-O-tetradecanoylphorbol-13-acetate-induced tumor promotion and oxidized DNA bases in mouse epidermis Carcinogenesis 18 1997 83 88
209. B. Sung, A.B. Kunnumakkara, G. Sethi, P. Anand, S. Guha, and B.B. Aggarwal Curcumin circumvents chemoresistance in vitro and potentiates the effect of thalidomide and bortezomib against human multiple myeloma in nude mice model Mol. Cancer Ther. 8 2009 959 970
210. S.S. Hecht, P.M. Kenney, M. Wang, N. Trushin, S. Agarwal, A.V. Rao, and P. Upadhyaya Evaluation of butylated hydroxyanisole, myo-inositol, curcumin, esculetin, resveratrol and lycopene as inhibitors of benzo [a] pyrene plus 4-(methylnitrosamino)-1-(3-pyridyl)-1-butanone-induced lung tumorigenesis in A/J mice Cancer Lett. 137 1999 123 130
211. S.E. Chuang, A.L. Cheng, J.K. Lin, and M.L. Kuo Inhibition by curcumin of diethylnitrosamine-induced hepatic hyperplasia, inflammation, cellular gene products and cell-cycle-related proteins in rats Food Chem. Toxicol. 38 2000 991 995
212. J. Ushida, S. Sugie, K. Kawabata, Q.V. Pham, T. Tanaka, K. Fujii, H. Takeuchi, Y. Ito, and H. Mori Chemopreventive effect of curcumin on N-nitrosomethylbenzylamine-induced esophageal carcinogenesis in rats Jpn. J. Cancer Res. 91 2000 893 898
213. M.V. Swamy, B. Citineni, J.M. Patlolla, A. Mohammed, Y. Zhang, and C.V. Rao Prevention and treatment of pancreatic cancer by curcumin in combination with omega-3 fatty acids Nutr. cancer 60 2008 81 89
214. N.K. Narayanan, D. Nargi, C. Randolph, and B.A. Narayanan Liposome encapsulation of curcumin and resveratrol in combination reduces prostate cancer incidence in PTEN knockout mice Int. J. Cancer 125 2009 1 8
215. S. Purkayastha, A. Berliner, S.S. Fernando, B. Ranasinghe, I. Ray, H. Tariq, and P. Banerjee Curcumin blocks brain tumor formation Brain Res. 1266 2009 130 138
216. J. Cao, L. Jia, H.M. Zhou, Y. Liu, and L.F. Zhong Mitochondrial and nuclear DNA damage induced by curcumin in human hepatoma G2 cells Toxicol. Sci. 9 2006 476 483
217. H. Wang, Y. Mao, A.Y. Chen, N. Zhou, E.J. LaVoie, and L.F. Liu Stimulation of topoisomerase II-mediated DNA damage via a mechanism involving protein thiolation Biochemistry 40 2001 3316 3323
218. C. Martín-Cordero, M. López-Lázaro, M. Gálvez, and Ayuso M. Jesús Curcumin as a DNA topoisomerase II poison J. Enzyme Inhib. Med. 18 2003 505 509
219. M. López-Lázaro Excessive superoxide anion generation plays a key role in carcinogenesis Int. J. Cancer 120 2007 1378 1380
220. J.E. Klaunig, and L.M. Kamendulis The role of oxidative stress in carcinogenesis Annu. Rev. Pharmacol. Toxicol. 44 2004 239 267
221. C. Syng-Ai, A.L. Kumari, and A. Khar Effect of curcumin on normal and tumor cells: role of glutathione and bcl-2 Mol. Cancer Ther. 3 2004 1101 1108
222. J. Fang, J. Lu, and A. Holmgren Thioredoxin reductase is irreversibly modified by curcumin a novel molecular mechanism for its anticancer activity J. Biol. Chem. 280 2005 25284 25290
223. M. López-Lázaro Dual role of hydrogen peroxide in cancer: possible relevance to cancer chemoprevention and therapy Cancer Lett. 252 2007 1 8
224. M. López-Lázaro Anticancer and carcinogenic properties of curcumin: considerations for its clinical development as a cancer chemopreventive and chemotherapeutic agent Mol. Nutr. Food Res. 52 2008 S103 S127
225. R.A. Sharma, S.A. Euden, S.L. Platton, D.N. Cooke, A. Shafayat, H.R. Hewitt, T.H. Marczylo, B. Morgan, D. Hemingway, and S.M. Plummer Phase I clinical trial of oral curcumin biomarkers of systemic activity and compliance Clin. Cancer Res. 10 2004 6847 6854
226. Y. Jiao, J. Wilkinson, X. Di, W. Wang, H. Hatcher, N.D. Kock, R. D'Agostino, M.A. Knovich, F.M. Torti, and S.V. Torti Curcumin, a cancer chemopreventive and chemotherapeutic agent, is a biologically active iron chelator Blood 113 2009 462 469
227. S.T. Dance-Barnes, N.D. Kock, J.E. Moore, E.Y. Lin, L.J. Mosley, R.B. D'Agostino, T.P. McCoy, A.J. Townsend, and M.S. Miller Lung tumor promotion by curcumin Carcinogenesis 30 2009 1016 1023
228. S. Swarnakar, K. Ganguly, P. Kundu, A. Banerjee, P. Maity, and A.V. Sharma Curcumin regulates expression and activity of matrix metalloproteinases 9 and 2 during prevention and healing of indomethacin-induced gastric ulcer J. Biol. Chem. 280 2005 9409 9415
229. C.R. Ireson, D.J. Jones, S. Orr, M.W. Coughtrie, D.J. Boocock, M.L. Williams, P.B. Farmer, W.P. Steward, and A.J. Gescher Metabolism of the cancer chemopreventive agent curcumin in human and rat intestine Cancer Epidemiol. Biomark. Prev. 11 2002 105 111
230. G. Garcea, D.P. Berry, D.J. Jones, R. Singh, A.R. Dennison, P.B. Farmer, R.A. Sharma, W.P. Steward, and A.J. Gescher Consumption of the putative chemopreventive agent curcumin by cancer patients: assessment of curcumin levels in the colorectum and their pharmacodynamic consequences Cancer Epidemiol. Biomark. Prev. 14 2005 120 125
231. S.K. Sandur, M.K. Pandey, B. Sung, K.S. Ahn, A. Murakami, G. Sethi, P. Limtrakul, V. Badmaev, and B.B. Aggarwal Curcumin, demethoxycurcumin, bisdemethoxycurcumin, tetrahydrocurcumin and turmerones differentially regulate anti-inflammatory and anti-proliferative responses through a ROS-independent mechanism Carcinogenesis 28 2007 1765 1773
232. G. Shoba, D. Joy, T. Joseph, M. Majeed, R. Rajendran, and P.S. Srinivas Influence of piperine on the pharmacokinetics of curcumin in animals and human volunteers Planta Med. 64 1998 353 356
233. C.K. Atal, R.K. Dubey, and J. Singh Biochemical basis of enhanced drug bioavailability by piperine: evidence that piperine is a potent inhibitor of drug metabolism J. Pharmacol. Exp. Ther. 232 1985 258 262
234. R.K. Bhardwaj, H. Glaeser, L. Becquemont, U. Klotz, S.K. Gupta, and M.F. Fromm Piperine, a major constituent of black pepper, inhibits human P-glycoprotein and CYP3A4 J. Pharmacol. Exp. Ther. 302 2002 645 650
235. C. Mancuso, and E. Barone Curcumin in clinical practice: myth or reality? Trends Pharmacol. Sci. 30 2009 333 334
236. M. Takahashi, S. Uechi, K. Takara, Y. Asikin, and K. Wada Evaluation of an oral carrier system in rats: bioavailability and antioxidant properties of liposome-encapsulated curcumin J. Agric. Food Chem. 57 2009 9141 9146
237. Y.M. Tsai, W.C. Jan, C.F. Chien, W.C. Lee, L.C. Lin, and T.H. Tsai Optimised nano-formulation on the bioavailability of hydrophobic polyphenol, curcumin, in freely-moving rats Food Chem. 127 2011 918 925
238. R. Ravichandran Pharmacokinetic study of nanoparticulate curcumin: oral formulation for enhanced bioavailability J. Biomed. Nanotechnol. 4 2013 291 299
239. R.L. Thangapazham, A. Puri, S. Tele, R. Blumenthal, and R.K. Maheshwari Evaluation of a nanotechnology-based carrier for delivery of curcumin in prostate cancer cells Int. J. Oncol. 32 2008 1119 1123
240. A. Mukerjee, and J.K. Vishwanatha Formulation, characterization and evaluation of curcumin-loaded PLGA nanospheres for cancer therapy Anticancer Res. 29 2009 3867 3875
241. V.R. Yadav, S. Prasad, R. Kannappan, J. Ravindran, M.M. Chaturvedi, L. Vaahtera, J. Parkkinen, and B.B. Aggarwal Cyclodextrin-complexed curcumin exhibits anti-inflammatory and antiproliferative activities superior to those of curcumin through higher cellular uptake Biochem. Pharmacol. 80 2010 1021 1032
242. Y. Gao, Z. Li, M. Sun, H. Li, C. Guo, J. Cui, A. Li, F. Cao, Y. Xi, H. Lou, and G. Zhai Preparation, characterization, pharmacokinetics, and tissue distribution of curcumin nanosuspension with TPGS as stabilizer Drug Dev. Ind. Pharm. 36 2010 1225 1234
243. P. Dandekar, R. Dhumal, R. Jain, D. Tiwari, G. Vanage, and V. Patravale Toxicological evaluation of pH-sensitive nanoparticles of curcumin: acute, sub-acute and genotoxicity studies Food Chem. Toxicol. 48 2010 2073 2089
244. Y. Gao, Z. Li, M. Sun, C. Guo, A. Yu, Y. Xi, and et al. Preparation and characterization of intravenously injectable curcumin nanosuspension Drug Deliv. 18 2011 131 142
245. N.S. Rejinold, P.R. Sreerekha, K.P. Chennazhi, S.V. Nair, and R. Jayakumar Biocompatible, biodegradable and thermo-sensitive chitosan-g-poly (N-isopropylacrylamide) nanocarrier for curcumin drug delivery Int. J. Biol. Macromol. 49 2011 161 172
246. M.K. Pandey, S. Kumar, R.K. Thimmulappa, V.S. Parmar, S. Biswal, and A.C. Watterson Design, synthesis and evaluation of novel PEGylated curcumin analogs as potent Nrf2 activators in human bronchial epithelial cells Eur. J. Pharm. Sci. 43 2011 16 24
247. L. Zhongfa, M. Chiu, J. Wang, W. Chen, W. Yen, P. Fan-Havard, and et al. Enhancement of curcumin oral absorption and pharmacokinetics of curcuminoids and curcumin metabolites in mice Cancer Chemother. Pharmacol. 69 2012 679 689
248. C. Li, Y. Zhang, T. Su, L. Feng, Y. Long, and Z. Chen Silica-coated flexible liposomes as a nanohybrid delivery system for enhanced oral bioavailability of curcumin Int. J. Nanomedicine 7 2012 5995 6002
249. H. Chen, J. Wu, M. Sun, C. Guo, A. Yu, F. Cao, L. Zhao, Q. Tan, and G. Zhai N-trimethyl chitosan chloride-coated liposomes for the oral delivery of curcumin J. Liposome Res. 22 2012 100 109
250. Y.L. Lin, Y.K. Liu, N.M. Tsai, J.H. Hsieh, C.H. Chen, C.M. Lin, and K.W. Liao A lipo-PEG-PEI complex for encapsulating curcumin that enhances its antitumor effects on curcumin-sensitive and curcumin-resistance cells Nanomedicine 8 2012 318 327
251. S.S. Dhule, P. Penfornis, T. Frazier, R. Walker, J. Feldman, G. Tan, J. He, A. Alb, V. John, and R. Pochampally Curcumin-loaded gamma-cyclodextrin liposomal nanoparticles as delivery vehicles for osteosarcoma Nanomedicine 8 2012 440 451
252. Y.B. Pawar, H. Purohit, G.R. Valicherla, B. Munjal, S.V. Lale, S.B. Patel, and A.K. Bansal Novel lipid based oral formulation of curcumin: development and optimization by design of experiments approach Int. J. Pharm. 436 2012 617 623
253. D. Ghosh, S.T. Choudhury, S. Ghosh, A.K. Mandal, S. Sarkar, A. Ghosh, K.D. Saha, and N. Das Nanocapsulated curcumin: oral chemopreventive formulation against diethylnitrosamine induced hepatocellular carcinoma in rat Chem. Biol. Interact. 195 2012 206 214
254. M.M. Yallapu, M.R. Dobberpuhl, D.M. Maher, M. Jaggi, and S.C. Chauhan Design of curcumin loaded cellulose nanoparticles for prostate cancer Curr. Drug Metab. 13 2012 120 128
255. K.L. Nair, A.K. Thulasidasan, G. Deepa, R.J. Anto, and G.S. Kumar Purely aqueous PLGA nanoparticulate formulations of curcumin exhibit enhanced anticancer activity with dependence on the combination of the carrier Int. J. Pharm. 425 2012 44 52
256. R. Feng, Z. Song, and G. Zhai Preparation and in vivo pharmacokinetics of curcumin-loaded PCL-PEG-PCL triblock copolymeric nanoparticles Int. J. Nanomedicine 7 2012 4089 4098
257. S. Alam, J.J. Panda, and V.S. Chauhan Novel dipeptide nanoparticles for effective curcumin delivery Int. J. Nanomedicine 7 2012 4207 4222
258. J.H. Park, H.A. Kim, and M. Lee Amphiphilic peptide carrier for the combined delivery of curcumin and plasmid DNA into the lungs Biomaterials 33 2012 6542 6550
259. N.P. Aditya, G. Chimote, K. Gunalan, R. Banerjee, S. Patankar, and B. Madhusudhan Curcuminoids-loaded liposomes in combination with arteether protects against plasmodium berghei infection in mice Exp. Parasitol. 131 2012 292 299
260. S. Marrache, and S. Dhar Engineering of blended nanoparticle platform for delivery of mitochondria-acting therapeutics Proc. Natl. Acad. Sci. 109 2012 16288 16293
261. R. Singh, H.H. Tonnesen, S. Kristensen, and K. Berg The influence of pluronics(R) on dark cytotoxicity, photocytotoxicity, localization and uptake of curcumin in cancer cells: studies of curcumin and curcuminoids XLIX Photochem. Photobiol. Sci. 12 2013 559 575
262. M.K. John, H. Xie, E.C. Bell, and D. Liang Development and pharmacokinetic evaluation of a curcumin co-solvent formulation Anticancer Res. 33 2013 4285 4291
263. N.B. Agarwal, S. Jain, D. Nagpal, N.K. Agarwal, P.K. Mediratta, and K.K. Sharma Liposomal formulation of curcumin attenuates seizures in different experimental models of epilepsy in mice Fundam. Clin. Pharmacol. 27 2013 169 172
264. J. Sun, C. Bi, H.M. Chan, S. Sun, Q. Zhang, and Y. Zheng Curcumin loaded solid lipid nanoparticles have prolonged in vitro antitumour activity, cellular uptake and improved in vivo bioavailability Colloids Surf. B: Biointerfaces 111C 2013 367 375
265. C. Gong, S. Deng, Q. Wu, M. Xiang, X. Wei, L. Li, X. Gao, B. Wang, L. Sun, Y. Chen, Y. Li, L. Liu, Z. Qian, and Y. Wei Improving antiangiogenesis and anti-tumor activity of curcumin by biodegradable polymeric micelles Biomaterials 34 2013 1413 1432
266. L. Liu, L. Sun, Q. Wu, W. Guo, L. Li, Y. Chen, Y. Li, C. Gong, Z. Qian, and Y. Wei Curcumin loaded polymeric micelles inhibit breast tumor growth and spontaneous pulmonary metastasis Int. J. Pharm. 443 2013 175 182
267. X. Chen, F. Zhi, X. Jia, X. Zhang, R. Ambardekar, Z. Meng, A.R. Paradkar, Y. Hu, and Y. Yang Enhanced brain targeting of curcumin by intranasal administration of a thermosensitive poloxamer hydrogel J. Pharm. Pharmacol. 65 2013 807 816
268. C.W. Liu, F. Xiong, H.Z. Jia, X.L. Wang, H. Cheng, Y.H. Sun, X.Z. Zhang, R.X. Zhuo, and J. Feng Graphene-based anticancer nanosystem and its biosafety evaluation using a zebrafish model Biomacromolecules 14 2013 358 366
269. R.K. Gangwar, G.B. Tomar, V.A. Dhumale, S. Zinjarde, R.B. Sharma, and S. Datar Curcumin conjugated silica nanoparticles for improving bioavailability and its anticancer applications J. Agric. Food Chem. 61 2013 9632 9637
270. S.F. Peng, C.Y. Lee, M.J. Hour, S.C. Tsai, D.H. Kuo, F.A. Chen, P.C. Shieh, and J.S. Yang Curcumin-loaded nanoparticles enhance apoptotic cell death of U2OS human osteosarcoma cells through the Akt-Bad signaling pathway Int. J. Oncol. 44 2014 238 246
271. H. Li, N. Zhang, Y. Hao, Y. Wang, S. Jia, H. Zhang, Y. Zhang, and Z. Zhang Formulation of curcumin delivery with functionalized single-walled carbon nanotubes: characteristics and anticancer effects in vitro Drug Deliv. 21 2014 379 387
272. N. Saengkrit, S. Saesoo, W. Srinuanchai, S. Phunpee, and U.R. Ruktanonchai Influence of curcumin-loaded cationic liposome on anticancer activity for cervical cancer therapy Colloids Surf. B: Biointerfaces 114 2014 349 356
273. S.S. Kumar, M. Surianarayanan, R. Vijayaraghavan, A.B. Mandal, and D.R. MacFarlane Curcumin loaded poly(2-hydroxyethyl methacrylate) nanoparticles from gelled ionic liquid: in vitro cytotoxicity and anti-cancer activity in SKOV-3 cells Eur. J. Pharm. Sci. 51 2014 34 44
274. S.C. Gupta, S. Patchva, and B.B. Aggarwal Therapeutic roles of curcumin: Lessons learned from clinical trials AAPS J. 15 2013 195 218
275. M. Kanai Therapeutic applications of curcumin for patients with pancreatic cancer World J. Gastroenterol. 20 2014 9384 9391
276. K.M. Terlikowska, A.M. Witkowska, M.E. Zujko, B. Dobrzycka, and S.J. Terlikowski Potential application of curcumin and its analogues in the treatment strategy of patients with primary epithelial ovarian cancer Int. J. Mol. Sci. 15 2014 21703 21722
277. J.J. Johnson, and H. Mukhtar Curcumin for chemoprevention of colon cancer cancer Lett. 255 2007 170 181
278. S.C. Gupta, S. Patchva, W. Koh, and B.B. Aggarwal Discovery of curcumin, a component of golden spice, and its miraculous biological activities Clin. Exp. Pharmacol. Physiol. 39 2012 283 299
279. W. Park, A.R. Amin, Z.G. Chen, and D.M. Shin New perspectives of curcumin in cancer prevention Cancer Prev. Res. 6 2013 387 400